Chemoinformatics in Molecular Docking and Drug Discovery.

Slides:



Advertisements
Similar presentations
SOMA2 – Drug Design Environment. Drug design environment – SOMA2 The SOMA2 project Tekes (National Technology Agency of Finland) DRUG2000 program.
Advertisements

Inhibitors of Pantothenate Synthetase: Initiating a Quest for New TB Drugs Reaz Uddin, Michael Brunsteiner, Pavel A. Petukhov* Department of Medicinal.
AutoDock 4 and AutoDock Vina -Brief Intruction
Improving enrichment rates A practical solution to an impractical problem Noel O’Boyle Cambridge Crystallographic Data Centre
Jürgen Sühnel Institute of Molecular Biotechnology, Jena Centre for Bioinformatics Jena / Germany Supplementary Material:
Molecular dynamics refinement and rescoring in WISDOM virtual screenings Gianluca Degliesposti University of Modena and Reggio Emilia Molecular Modelling.
Establishing a Successful Virtual Screening Process Stephen Pickett Roche Discovery Welwyn.
Molecular Docking G. Schaftenaar Docking Challenge Identification of the ligand’s correct binding geometry in the binding site ( Binding Mode ) Observation:
Two Examples of Docking Algorithms With thanks to Maria Teresa Gil Lucientes.
Novel Dihydrofolate Reductase Inhibitors. Structure- Based versus Diversity-Based Design and High- Throughput Synthesis and Screening Pierre C. Wyss, Paul.
Summary Molecular surfaces QM properties presented on surface Compound screening Pattern matching on surfaces Martin Swain Critical features Dave Whitley.
Luddite: An Information Theoretic Library Design Tool Jennifer L. Miller, Erin K. Bradley, and Steven L. Teig July 18, 2002.
Docking of Protein Molecules
FLEX* - REVIEW.
Summary Protein design seeks to find amino acid sequences which stably fold into specific 3-D structures. Modeling the inherent flexibility of the protein.
An Integrated Approach to Protein-Protein Docking
BL5203: Molecular Recognition & Interaction Lecture 5: Drug Design Methods Ligand-Protein Docking (Part I) Prof. Chen Yu Zong Tel:
Molecular Docking Using GOLD Tommi Suvitaival Seppo Virtanen S Basics for Biosystems of the Cell Fall 2006.
Super fast identification and optimization of high quality drug candidates.
In Silico Design of Selective Estrogen Receptor Modulators from Triazoles and Imines Joey Salisbury Dr. John C. Williams Small Molecules/Large Molecules.
Virtual Screening protein-ligand interactions, inhibitors, SBDD –kinetics, competitive, slow, aggregators –H-bonding, halogens, co-factors, metal ions.
Chemoinformatics in Drug Design
Protein Structure and Drug Discovery Workshop To be held at Monash University, Mebourne, Australia October 3 rd to 4 th 2006 Molecular Visualization Learn.
Bioinformatics Ayesha M. Khan Spring Phylogenetic software PHYLIP l 2.
Important Points in Drug Design based on Bioinformatics Tools History of Drug/Vaccine development –Plants or Natural Product Plant and Natural products.
eHiTS Score Darryl Reid, Zsolt Zsoldos, Bashir S. Sadjad, Aniko Simon, The next stage in scoring function evolution: a new statistically.
Drug Design Process Discovery Phase. Tripos Software n SYBYL & its modules SYBYL, Concord, MOLCAD, SiteId, Advanced Computation, GASP, DISCOtech, HQSAR,
Computational Techniques in Support of Drug Discovery October 2, 2002 Jeffrey Wolbach, Ph. D.
Combinatorial Chemistry and Library Design
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
A genetic algorithm for structure based de-novo design Scott C.-H. Pegg, Jose J. Haresco & Irwin D. Kuntz February 21, 2006.
Introduction to Chemoinformatics Irene Kouskoumvekaki Associate Professor December 12th, 2012 Biological Sequence Analysis course.
High-Throughput Virtual Molecular Docking: Hadoop Implementation of AutoDock4 on a Private Cloud Sally R. Ellingson Graduate Research Assistant Center.
Protein Molecule Simulation on the Grid G-USE in ProSim Project Tamas Kiss Joint EGGE and EDGeS Summer School.
Function first: a powerful approach to post-genomic drug discovery Stephen F. Betz, Susan M. Baxter and Jacquelyn S. Fetrow GeneFormatics Presented by.
SELECTION OF NEW TARGET PROTEINS FOR DRUG DESIGN IN GENOME OF MYCOBACTERIUM TUBERCULOSIS Alexander V. Veselovsky V.N. Orechovich Institute of Biomedical.
In silico discovery of inhibitors using structure-based approaches Jasmita Gill Structural and Computational Biology Group, ICGEB, New Delhi Nov 2005.
Page 1 SCAI Dr. Marc Zimmermann Department of Bioinformatics Fraunhofer Institute for Algorithms and Scientific Computing (SCAI) Grid-enabled drug discovery.
CS5263 Bioinformatics Lecture 20 Practical issues in motif finding Final project.
SimBioSys Inc.© Slide #1 Enrichment and cross-validation studies of the eHiTS high throughput screening software package.
Altman et al. JACS 2008, Presented By Swati Jain.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
1/20 Study of Highly Accurate and Fast Protein-Ligand Docking Method Based on Molecular Dynamics Reporter: Yu Lun Kuo
Hierarchical Database Screenings for HIV-1 Reverse Transcriptase Using a Pharmacophore Model, Rigid Docking, Solvation Docking, and MM-PB/SA Junmei Wang,
Biochemistry : Chemistry in biological systems. Biochemistry is the study of the chemical processes and transformations in living organisms Key metabolic.
Computer-aided drug discovery (CADD)/design methods have played a major role in the development of therapeutically important small molecules for several.
R L R L L L R R L L R R L L water DOCKING SIMULATIONS.
Structure- based Structure-based computer-aided drug discovery (SB-CADD) approach: helps to design and evaluate the quality, in terms of affinity, of series.
Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013.
Design of a Compound Screening Collection Gavin Harper Cheminformatics, Stevenage.
Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search Engine Ajay N. Jain UCSF Cancer Research Institute and Comprehensive.
Elon Yariv Graduate student in Prof. Nir Ben-Tal’s lab Department of Biochemistry and Molecular Biology, Tel Aviv University.
Docking and Virtual Screening Using the BMI cluster
Molecular Modeling in Drug Discovery: an Overview
Page 1 Computer-aided Drug Design —Profacgen. Page 2 The most fundamental goal in the drug design process is to determine whether a given compound will.
Dhanvantari GenOME to hit
Generating, Maintaining, and Exploiting Diversity in a Memetic Algorithm for Protein Structure Prediction Mario Garza-Fabre, Shaun M. Kandathil, Julia.
Simplified picture of the principles used for multiple copy simultaneous search (MCSS) and for computational combinatorial ligand design (CCLD). Simplified.
APPLICATIONS OF BIOINFORMATICS IN DRUG DISCOVERY
DATA MINING FOR SMALL MOLECULE ALLOSTERIC INHIBITORS
Molecular Docking Profacgen. The interactions between proteins and other molecules play important roles in various biological processes, including gene.
International Chemical Design & Discovery Course 2017
Virtual Screening.
Ligand Docking to MHC Class I Molecules
An Integrated Approach to Protein-Protein Docking
Alexey Sulimov, Ekaterina Katkova, Vladimir Sulimov,
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Mr.Halavath Ramesh 16-MCH-001 Dept. of Chemistry Loyola College University of Madras-Chennai.
Presentation transcript:

Chemoinformatics in Molecular Docking and Drug Discovery

2 The Docking Problem Given: receptor binding pocket and ligand. Task: quickly find correct binding pose. Two critical modules: 1.Search Algorithm 2.Scoring Function

3 Definitions pKd = measures tightness of binding pKi = measures ability to inhibit Mechanisms of action—for instance: – Competitive inhibition (most typical docking case) – Allosteric inhibition (bind to different pocket) – Allosteric activation

4 Challenges Search algorithm – Speed (5M compounds or more) – Local minima – High-dimensional search space Scoring function – Strict control of false positives – Good correlation with pKd – Multiple terms – No consensus – Non-additive effects (solvation, hydrophobic interactions) Note: pKd does not always correspond with activity ADME concerns

5 Examples of Docking Search Algorithms – Genetic Algorithms – Incremental Construction – Fragment Reconstruction – Gradient Descent – Simulated Annealing and other MC Variants – Tiered Scoring Functions fast screening functions slow accurate functions

6 High Dimensionality: Flexibility Most algorithms handle ligand flexibility but do NOT handle receptor flexibility. Iterative Docking to find alternate conformations of the protein – Dock flexible ligand – Minimize receptor holding ligand rigid – Repeat

7 Scoring Function Energy of Interaction (pKd) Electrostatics Van der Waal’s interactions Hydrogen bonds Solvation effects Loss of entropy Active site waters

8 ADME ADME concerns can be more important than bioactivity. Most of these properties are difficult to predict. Absorption Distribution Metabolism Excretion

9 Docking Programs Dock (UCSF) Autodock (Scripps) Glide (Schrodinger) ICM (Molsoft) FRED (Open Eye) Gold, FlexX, etc.

10 Evaluation of Docking Programs Evaluation of library ranking efficacy in virtual screening. J Comput Chem Jan 15;26(1): Evaluation of docking performance: comparative data on docking algorithms. J Med Chem Jan 29;47(3): Impact of scoring functions on enrichment in docking-based virtual screening: an application study on renin inhibitors. J Chem Inf Comput Sci May-Jun;44(3):

11 Cluster Based Computing Trivially parallelizable – Divide ligand input files – Some programs have specific parallel implementations (PVM or MPI implementations,…) Commercial licenses are expensive

12 Consensus Scoring Combining independent scoring functions and docking algorithms can improve results Most common method: sort using the sum of the ranks of component scores More sophisticated methods exist Consensus scoring criteria for improving enrichment in virtual screening. J Chem Inf Model Jul-Aug;45(4):

13 Adding Chemical Informatics Docking results can be improved by using chemical information about the hits. Chemicals which bind the same protein tend to have similar structure. Iterating back and forth between docking and searching large DB. Use other filters and predictive modules (e.g. Lipinski rules) ALGORITHM: 1.Dock and rank a chemical database 2.Create a bayesian model of the fingerprints of the top hits. 3.Re-rank the database based on their likelihood according to the bayesian model Finding More Needles in the Haystack: A Simple and Efficient Method for Improving High-Throughput Docking Results J. Med. Chem., 47 (11), , 2004.

14 Visualization Viewers must be able to scroll through tens or hundreds of small molecule hits Accessible viewers designed for this problem: – VIDA from OpenEye (free for academics) – ViewDock module of Chimera from UCSF (free, open source)

15 Long-term Goal of Drug Discovery LTDD (Low Throughput Drug Design) instead of HTVS (High Throughput Virtual Screening) Common ground: explore virtual space

Drug Discovery Case Study: Tuberculosis

17 Mycobacterium Tuberculosis Very thick, waxy cell wall Tuberculosis

18 Cell wall lipids: Important for pathogen virulence, survival and latency 6 different ACCase  subunits, AccD1-6 Acyl-CoA Tuberculosis 7 th cause of death 1 in 3 people have TB Leading AIDS death cause Multi-drug resistant Mycobacterium tuberculosis Homologs of PccB Focus on AccD4-6 >30 C fatty acid The Cell Wall: Key to Pathogen Survival Sugar 10% of genome

19 Tuberculosis (TB): An old foe

20 The White Death Frederic Chopin John Keats

21 TB: still a real threat, because….. Its ability to stay alive Multi-Drug Resistant (Super TB strain)

22 Cell wall lipids: Important for pathogen virulence, survival and latency 6 different ACCase  subunits, AccD1-6 Acyl-CoA Substrate specificity for AccD4-6? Tuberculosis 7 th cause of death worldwide 1 in 3 people have TB Leading cause AIDS death Multi-drug resistant Mycobacterium tuberculosis Homologs of PccB Focus on AccD4-6 >30 C fatty acid The Cell Wall: Key to Pathogen Survival Sugar 10% of genome

23 AccD5 Protein Structures AccD4 (3.3 Å)Solved AccD5 (2.9 Å)AccD6 (2.7 Å)

24 Structure of AccD5

25 Structure-Based Drug Design Crystals & Crystal structure 1. High throughput screening Lead compound2. Virtual Screening 3. Combinatorial chemistry Enzyme assay TB ACCase, AccD5

26 The Computational/Experimental Loop Assay Docking Similarity Search

27 Docking Results Diversity set (1990) from NCI

28 NCI (Lead 1) NCI (Lead 2) 300uM 50uM300uM50-100uM

29 Structure-Based Drug Design Identified AccD5 Inhibitors  New TB drug lead K I = 4.7  M, K GI = ~50  M T. Lin, M. Melgar, S. J. Swamidass, J. Purdon, T. Tseng, G. Gago, D. Kurth, P. Baldi, H. Gramajo, and S. Tsai. PNAS, 103, 9, , (2006). US Patent pending.

30 Chemical similarity: Docking: Two Strategies

31 AccD5 Enzyme necessary for mycolic acid biosynthesis in M. tuberculosis.